Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 2/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | GSK3A | P49840 | 2/20 | 0.38 |
| ▸ | GSK3B | P49841 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | WRN | Q14191 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | LPO | P22079 | 4/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3630207 | 1.00 | P2RX4 (0.48) | P2RX4BCHEMGLLALDH1A1GSK3A | |
| Propionic Acid SCHEMBL28919819 | 0.88 | ALDH1A1 (0.43) | P2RX4BCHEMGLLALDH1A1GSK3A | |
| SCHEMBL13674056 | 0.85 | P2RX4 (0.42) | P2RX4BCHEMGLLALDH1A1GSK3A | |
| SCHEMBL2105111 | 0.78 | P2RX4 (0.40) | P2RX4BCHELPOPSEN1PSEN2 | |
| SCHEMBL1678307 | 0.76 | GSK3A (0.57) | BCHEMGLLALDH1A1GSK3AGSK3B | |
| SCHEMBL19479170 | 0.75 | ALDH1A1 (0.33) | MGLLALDH1A1GSK3AGSK3BBLM | |
| SCHEMBL8014569 | 0.75 | BCHE (0.47) | BCHEMGLLALDH1A1BLMHPGD | |
| SCHEMBL4463617 | 0.73 | ALDH1A1 (0.39) | P2RX4MGLLALDH1A1GSK3AGSK3B | |
| SCHEMBL9642610 | 0.72 | P2RX4 (0.34) | P2RX4BCHEMGLLALDH1A1GSK3A | |
| SCHEMBL18485436 | 0.72 | ALDH1A1 (0.44) | BCHEMGLLALDH1A1GSK3AGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059920-A | Dioxetane chemiluminescent probe suitable for bio-orthogonal catalytic reaction and synthesis and application thereof | 华南理工大学 | 2026-05-19 | — | — | CN | claimed |
| CN-120005123-A | Acrylic ester block copolymer resin, photoresist, and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119930866-A | Catalyst component containing pyrroline compound, preparation method thereof, olefin polymerization catalyst, olefin polymerization method and olefin polymer | 中国石油化工股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-118526608-A | Nanometer medicine for preventing and/or treating retinoblastoma and preparation method and application thereof | 中山大学附属第五医院 | 2024-08-23 | — | — | CN | claimed |
| CN-117647913-A | Negative photosensitive resin composition, application thereof, hardening film, preparation thereof and electronic device | 深圳市道尔顿电子材料股份有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-116904143-A | Room-temperature-cured temperature-resistant PMMA adhesive and manufacturing method thereof | 浙江华帅特新材料科技有限公司 | 2023-10-20 | — | — | CN | claimed |
| EP-3552023-B1 | MAPPING PROTEIN BINDING SITES AND CONFORMATIONAL EPITOPES USING CYSTEINE LABELLING AND SURFACE DISPLAY LIBRARY | INDIAN INST SCIENT (IN) | 2022-04-27 | — | — | EP | claimed |
| US-11221339-B2 | Mapping protein binding sites and conformational epitopes using cysteine labelling and surface display library | INDIAN INSTITUTE OF SCIENCE (IN) | 2022-01-11 | — | — | US | claimed |
| CN-109432449-B | Iron complex MRI contrast agent and preparation method and application thereof | 华南师范大学 | 2021-07-30 | — | — | CN | claimed |
| US-20200399428-A1 | SYSTEMS, METHODS AND HYDROGELS FOR CELL CULTURE AND ANALYSIS | PHENOMEX INC. (US) | 2020-12-24 | — | — | US | claimed |
| CN-1271115-C | Poly glycol long chain fatty alkyl maleimide derivative and its medicinal combination | JIANKAI SCIENCE AND TECHNOLOGY (CN) | 2006-08-23 | — | — | CN | claimed |
| JP-2006512445-A | — | — | 2006-04-13 | — | — | JP | claimed |
| CN-1732206-A | Hydrolytically stable maleimide-terminated polymers | NEKTAR THERAPEUTICS AL CORP (US) | 2006-02-08 | — | — | CN | claimed |
| US-20050249662-A1 | Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules | COMMISSARIAT A L'ENERGIE (FR) | 2005-11-10 | — | — | US | claimed |
| EP-1578842-A2 | HYDROLYTICALLY STABLE MALEIMIDE-TERMINATED POLYMERS | Nektar Therapeutics Al, Corporation (US) | 2005-09-28 | — | — | EP | claimed |
| EP-1517903-A2 | MARKED MALEIMIDE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR MARKING MACROMOLECULES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2005-03-30 | — | — | EP | claimed |
| US-20040204548-A1 | Hydrolytically stable maleimide-terminated polymers | NEKTAR THERAPEUTICS | 2004-10-14 | — | — | US | claimed |
| WO-2004060965-A2 | HYDROLYTICALLY STABLE MALEIMIDE-TERMINATED POLYMERS | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2004-07-22 | — | — | WO | claimed |
| CN-1511860-A | Poly glycol long chain fatty alkyl maleimide derivative and its medicinal combination | 北京键凯科技有限公司 | 2004-07-14 | — | — | CN | claimed |
| WO-2004002984-A2 | MARKED MALEIMIDE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR MARKING MACROMOLECULES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2004-01-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050249662-A1 | Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules | CRBN, NR2E3, NR2C2 | P2RX4 1558/4885BCHE 2340/4885MGLL 4532/4885 |
| US-20200399428-A1 | SYSTEMS, METHODS AND HYDROGELS FOR CELL CULTURE AND ANALYSIS | HLCS, CD63, CD44 | P2RX4 3081/4885BCHE 2942/4885MGLL 1012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.